CFTR and cystic fibrosis: This combined treatment might lead to unmet levels of functional CFTR production in CF cells, through the combination of two complementary activities, i.e., the miR-335-5p mediated up-regulation of CFTR production and the VX809 (or TMA)-dependent correction.